Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment.

Bao, Shihui; Zheng, Hailun; Ye, Jinyao; Huang, Huirong; Zhou, Bin; Yao, Qing; Lin, Guangyong; Zhang, Hailin; Kou, Longfa; Chen, Ruijie.

Afiliação

Bao S; Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Zheng H; Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Wenzhou, China.
Ye J; Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Huang H; Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Wenzhou, China.
Zhou B; Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Yao Q; Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Wenzhou, China.
Lin G; The Second School of Medicine, Wenzhou Medical University, Wenzhou, China.
Zhang H; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Kou L; Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Chen R; Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Wenzhou, China.